Guggenheim Capital’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $258K | Sell |
15,644
-10,088
| -39% | -$166K | ﹤0.01% | 1565 |
|
|
2026
Q1 | $419K | Sell |
25,732
-11,692
| -31% | -$183K | ﹤0.01% | 1261 |
|
|
2025
Q4 | $556K | Buy |
+37,424
| New | +$529K | ﹤0.01% | 1229 |
|
|
2022
Q3 | – | Sell |
-17,218
| Closed | -$219K | – | 2029 |
|
|
2022
Q2 | $219K | Buy |
17,218
+976
| +6% | +$12.5K | ﹤0.01% | 1909 |
|
|
2022
Q1 | $210K | Buy |
+16,242
| New | +$214K | ﹤0.01% | 2028 |
|
|
2021
Q4 | – | Sell |
-17,454
| Closed | -$340K | – | 2209 |
|
|
2021
Q3 | $340K | Buy |
17,454
+6,069
| +53% | +$120K | ﹤0.01% | 1884 |
|
|
2021
Q2 | $259K | Sell |
11,385
-100
| -0.9% | -$2.08K | ﹤0.01% | 2071 |
|
|
2021
Q1 | $211K | Buy |
+11,485
| New | +$188K | ﹤0.01% | 2073 |
|
|
2020
Q2 | – | Sell |
-32,638
| Closed | -$264K | – | 1936 |
|
|
2020
Q1 | $264K | Sell |
32,638
-8,534
| -21% | -$101K | ﹤0.01% | 1575 |
|
|
2019
Q4 | $518K | Sell |
41,172
-13,847
| -25% | -$149K | ﹤0.01% | 1580 |
|
|
2019
Q3 | $492K | Buy |
55,019
+1,275
| +2% | +$11.1K | ﹤0.01% | 1623 |
|
|
2019
Q2 | $460K | Sell |
53,744
-6,088
| -10% | -$48.1K | ﹤0.01% | 1693 |
|
|
2019
Q1 | $454K | Sell |
59,832
-5,839
| -9% | -$46.9K | ﹤0.01% | 1730 |
|
|
2018
Q4 | $543K | Buy |
65,671
+4,933
| +8% | +$47.2K | ﹤0.01% | 1641 |
|
|
2018
Q3 | $602K | Buy |
60,738
+25,055
| +70% | +$259K | ﹤0.01% | 1881 |
|
|
2018
Q2 | $349K | Buy |
+35,683
| New | +$350K | ﹤0.01% | 2135 |
|
|
2017
Q4 | – | Sell |
-375,040
| Closed | -$3.88M | – | 2798 |
|
|
2017
Q3 | $3.88M | Buy |
375,040
+63,909
| +21% | +$590K | 0.01% | 1211 |
|
|
2017
Q2 | $2.57M | Sell |
311,131
-107,649
| -26% | -$808K | 0.01% | 1445 |
|
|
2017
Q1 | $3.01M | Sell |
418,780
-77,399
| -16% | -$561K | 0.01% | 1346 |
|
|
2016
Q4 | $3.54M | Buy |
496,179
+301,756
| +155% | +$2.1M | 0.01% | 1234 |
|
|
2016
Q3 | $1.41M | Sell |
194,423
-20,426
| -10% | -$130K | ﹤0.01% | 1853 |
|
|
2016
Q2 | $1.26M | Buy |
214,849
+815
| +0.4% | +$5.4K | ﹤0.01% | 1880 |
|
|
2016
Q1 | $1.36M | Sell |
214,034
-222,859
| -51% | -$1.2M | ﹤0.01% | 1840 |
|
|
2015
Q4 | $2.8M | Buy |
436,893
+210,699
| +93% | +$1.32M | 0.01% | 1373 |
|
|
2015
Q3 | $1.32M | Sell |
226,194
-6,168
| -3% | -$45.7K | ﹤0.01% | 1931 |
|
|
2015
Q2 | $2.03M | Sell |
232,362
-53,956
| -19% | -$453K | 0.01% | 1756 |
|
|
2015
Q1 | $2.29M | Sell |
286,318
-379,795
| -57% | -$2.84M | 0.01% | 1659 |
|
|
2014
Q4 | $5.17M | Buy |
666,113
+643,321
| +2,823% | +$4.69M | 0.01% | 1107 |
|
|
2014
Q3 | $147K | Buy |
+22,792
| New | +$176K | ﹤0.01% | 2863 |
|
|
2013
Q4 | – | Sell |
-2,415,293
| Closed | -$10.5M | – | 3251 |
|
|
2013
Q3 | $10.5M | Buy |
+2,415,293
| New | +$11M | 0.04% | 822 |
|
Other funds holding SEM
GCL
AA
DAM
PAMP
Guggenheim Capital's SEM Position: Q2 2026 in Review
Guggenheim Capital reduced its Select Medical (SEM) stake by 39% in Q2 2026, selling an estimated $166K and leaving 15,644 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #1565.
Guggenheim Capital first reported a position in SEM in Q3 2013 and has held it in 30 quarters since. The position peaked at $10.5M in Q3 2013. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.
- Guggenheim Capital held 15,644 shares of Select Medical worth $258K as of Q2 2026.
- Guggenheim Capital sold 10,088 Select Medical shares in Q2 2026, an estimated $166K.
- Select Medical made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1565 holding.
- Guggenheim Capital first reported a position in Select Medical in Q3 2013 and has held it in 30 quarters since.
- Guggenheim Capital's Select Medical position peaked at $10.5M in Q3 2013.
- 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.